Viewing Study NCT05322720


Ignite Creation Date: 2025-12-25 @ 4:25 AM
Ignite Modification Date: 2026-03-10 @ 8:06 PM
Study NCT ID: NCT05322720
Status: UNKNOWN
Last Update Posted: 2022-04-12
First Post: 2022-03-10
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: HR Positive, HER2 Negative Advanced Breast Cancer With Progression After Endocrine Therapy
Sponsor: Taizhou EOC Pharma Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module